Rosalind Advisors, Inc.
CIK 1622627 · Holdings on Mar 31, 2024 · First reported Apr 25, 2024
Top ten holdings
Q1 2024- MYO7.48%
- LYRA6.66%
- MDWD6.48%
- OPTN6.20%
- XERS5.83%
- CMPS5.71%
- CYBN5.40%
- ABVX5.06%
- VRDN4.91%
- DCTH4.63%
Share classes counted separately58.36%
Portfolio value by quarter
What changed this quarter?
Within preview · weight change- 85209E109Weight decreased · -2.78 pp3.89% → 1.11%Shares -77.97K (-4.92%)
- CLRBWeight decreased · -2.34 pp4.65% → 2.31%Shares -1.38M (-69.01%)
- VRDNWeight decreased · -1.66 pp6.57% → 4.91%Shares -60.33K (-16.74%)
Weight = security value ÷ total reported holdings value. Changes are in percentage points; price moves also affect weights, so they are not trade sizes.
Top 10 holdings 27
USD · B = billion · M = million; expand a row for exact values| # | Security | Value | Weight | Quantity | Weight / quantity change | Activity | |
|---|---|---|---|---|---|---|---|
| 01 | MYOMYOMO INCCOM NEW View history and evidence | $8.00M | 7.48% | 2.45M shares | 8.05% → 7.48%-0.57 pp +527.83K (+27.49%) | Added | ↗▾ |
| 02 | LYRALYRA THERAPEUTICS INC View history and evidence | $7.12M | 6.66% | 1.14M shares | 8.28% → 6.66%-1.62 pp -744.20K (-39.40%) | Reduced | ↗▾ |
| 03 | MDWDMEDIWOUND LTDSHS NEW View history and evidence | $6.93M | 6.48% | 485.99K shares | 5.16% → 6.48%+1.32 pp -120.76K (-19.90%) | Reduced | ↗▾ |
| 04 | OPTNOPTINOSE INC View history and evidence | $6.63M | 6.20% | 4.54M shares | 5.27% → 6.20%+0.93 pp -344.09K (-7.04%) | Reduced | ↗▾ |
| 05 | XERSXERIS BIOPHARMA HOLDINGS INC View history and evidence | $6.23M | 5.83% | 2.82M shares | 6.97% → 5.83%-1.14 pp -723.51K (-20.42%) | Reduced | ↗▾ |
| 06 | CMPSCOMPASS PATHWAYS PLCSPONSORED ADS View history and evidence | $6.11M | 5.71% | 734.00K shares | 5.85% → 5.71%-0.14 pp -64.50K (-8.08%) | Reduced | ↗▾ |
| 07 | CYBNCYBIN INC View history and evidence | $5.77M | 5.40% | 13.96M shares | Prior unavailable +13.96M | New | ↗▾ |
| 08 | ABVXABIVAX SA-ADRSPONSORED ADS View history and evidence | $5.41M | 5.06% | 378.42K shares | Prior unavailable +378.42K | New | ↗▾ |
| 09 | VRDNVIRIDIAN THERAPEUTICS INC View history and evidence | $5.25M | 4.91% | 300.00K shares | 6.57% → 4.91%-1.66 pp -60.33K (-16.74%) | Reduced | ↗▾ |
| 10 | DCTHDELCATH SYSTEMS INCCOM NEW View history and evidence | $4.96M | 4.63% | 1.04M shares | 3.62% → 4.63%+1.01 pp 0 (0.00%) | Unchanged | ↗▾ |
Options overlay 3
$79.50K notionalPut and Call positions are separate. Notional is based on underlying securities, not option premium, market value or net exposure. Quantities are underlying shares.
| Security | Put / Call | Underlying shares | Notional | Quantity change | |
|---|---|---|---|---|---|
XBISS SPDR S&P BIOTECH ETFS&P BIOTECH View history and evidence | Put | 50.00K | $72.50K | -450.00K (-90.00%) | ▾ |
QQQ 06.16.28 P590June 28 Puts on QQQ USUNIT SER 1 View history and evidence | Put | 100.00K | $7.00K | -800.00K (-88.89%) | ▾ |
AMLXAMYLYX PHARMACEUTICALS INCCALL View history and evidence | Call | 50.00K | $0.00 | +50.00K | ▾ |
3 / 3 options · preview only
Exited positions 8
| Security | Type | Shares out | Value out | Previous filing | This filing |
|---|---|---|---|---|---|
| CATB ASTRIA THERAPEUTICS INC | Non-derivative | -1,128,708 | -$8.67M | SEC filing ↗ | SEC filing ↗ |
| MDGL MADRIGAL PHARMACEUTICALS INC | Non-derivative | -25,000 | -$5.78M | SEC filing ↗ | SEC filing ↗ |
| SRPT SAREPTA THERAPEUTICS INC | Non-derivative | -57,400 | -$5.54M | SEC filing ↗ | SEC filing ↗ |
3 / 8 preview exits. Up to 30 exit records are previewed. Exit means absent from the current filing; execution date, price and proceeds are unknown.
Every number has a source.
CIK 1622627 · Period 2024-03-31
Data loaded 2026-09-23 · First reported 2024-04-25
Amendments and versions
{
"amendments_merged": null,
"prior_versions": null,
"cover_table_value": 107020362
}Research all 34 reported holdings.
This page includes 30 of 34 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.
- Download CSV
- Earlier quarters
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#portfolio-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. This page lists 30 of 34 current positions (options included); totals and weights use the complete filing.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
get_institutional_portfolio
{"cik":"1622627","quarter":"2024Q1","page_size":100}
get_institutional_manager_history
{"cik":"1622627","page_size":100}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.